Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares IssuedShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

Cannabis Bioscience International Holdings (CBIH) Cash from Operations (2023 - 2026)

Cannabis Bioscience International Holdings filings provide 4 years of Cash from Operations readings, the most recent being 14597.0 for Q1 2026.

  • On a quarterly basis, Cash from Operations rose 82.37% to 14597.0 in Q1 2026 year-over-year; TTM through Feb 2026 was 268114.0, a 25.47% increase, with the full-year FY2025 number at 329627.0, up 31.24% from a year prior.
  • Cash from Operations reached 14597.0 in Q1 2026 per CBIH's latest filing, down from 5493.0 in the prior quarter.
  • The five-year high for Cash from Operations was 5493.0 in Q4 2025, with the low at 221247.0 in Q4 2023.
  • A 4-year average of 101680.08 and a median of 82812.0 in 2025 define the central range for Cash from Operations.
  • Year-over-year, Cash from Operations surged 95.49% in 2024 and then crashed 812.43% in 2025.
  • Year by year, Cash from Operations stood at 221247.0 in 2023, then soared by 67.42% to 72090.0 in 2024, then surged by 92.38% to 5493.0 in 2025, then crashed by 165.74% to 14597.0 in 2026.
  • Per Business Quant, the three most recent readings for CBIH's Cash from Operations are 14597.0 (Q1 2026), 5493.0 (Q4 2025), and 103712.0 (Q3 2025).